Takeda announced it was considering a bid for Western rival Shire, which could potentially create a global top-10 drugmaker with a market value of more than $80 billion.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.